drugset / Trial / NCT02496910

PK Study of YH22162 FDC Compared to Combination of Twynsta and Hygroton

NCT02496910

Phase 1 Completed 180 enrolled Yuhan Corporation
RandomizedCrossoverOpen-label

Summary

This is a Randomized, open-label, single-dose, 2-treatment, 2-period, 2-sequence crossover design.

Timeline

Start
2015-06
Primary completion
2015-09
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amlodipine Other / unclassified 5 mg Oral
Comparator Chlorthalidone Other / unclassified 25 mg Oral
Comparator Telmisartan Other / unclassified 80 mg Oral
Subject YH22162 Unknown Oral

Indications